Page last updated: 2024-11-02

pentoxifylline and Glomerulonephritis, Membranous

pentoxifylline has been researched along with Glomerulonephritis, Membranous in 2 studies

Glomerulonephritis, Membranous: A type of glomerulonephritis that is characterized by the accumulation of immune deposits (COMPLEMENT MEMBRANE ATTACK COMPLEX) on the outer aspect of the GLOMERULAR BASEMENT MEMBRANE. It progresses from subepithelial dense deposits, to basement membrane reaction and eventual thickening of the basement membrane.

Research Excerpts

ExcerptRelevanceReference
"Treatment with pentoxifylline for 6 months resulted in a significant reduction of mean UPE (p < 0."6.78Effect of add-on pentoxifylline on proteinuria in membranous glomerulonephritis: a 6-month placebo-controlled trial. ( Abbasi, MR; Ahmadi, F; Badri, S; Dashti-Khavidaki, S; Khalili, H; Mahdavi-Mazdeh, M, 2013)
"Treatment with pentoxifylline for 6 months resulted in a significant reduction of mean UPE (p < 0."2.78Effect of add-on pentoxifylline on proteinuria in membranous glomerulonephritis: a 6-month placebo-controlled trial. ( Abbasi, MR; Ahmadi, F; Badri, S; Dashti-Khavidaki, S; Khalili, H; Mahdavi-Mazdeh, M, 2013)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Badri, S1
Dashti-Khavidaki, S1
Ahmadi, F1
Mahdavi-Mazdeh, M1
Abbasi, MR1
Khalili, H1
Ducloux, D1
Bresson-Vautrin, C1
Chalopin, J1

Trials

1 trial available for pentoxifylline and Glomerulonephritis, Membranous

ArticleYear
Effect of add-on pentoxifylline on proteinuria in membranous glomerulonephritis: a 6-month placebo-controlled trial.
    Clinical drug investigation, 2013, Volume: 33, Issue:3

    Topics: Adult; Female; Glomerulonephritis, Membranous; Humans; Male; Middle Aged; Pentoxifylline; Placebos;

2013

Other Studies

1 other study available for pentoxifylline and Glomerulonephritis, Membranous

ArticleYear
Use of pentoxifylline in membranous nephropathy.
    Lancet (London, England), 2001, May-26, Volume: 357, Issue:9269

    Topics: Adult; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerulonephritis, Membranous; Humans;

2001